<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>T. Aslesh | Moulton Research Group</title><link>https://Athos213.github.io/MoultonResearchGroup/author/t.-aslesh/</link><atom:link href="https://Athos213.github.io/MoultonResearchGroup/author/t.-aslesh/index.xml" rel="self" type="application/rss+xml"/><description>T. Aslesh</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Tue, 01 Mar 2022 00:00:00 +0000</lastBuildDate><image><url>https://Athos213.github.io/MoultonResearchGroup/media/logo_hu3899385728f8d4f84067ee8fa4c80c53_123815_300x300_fit_lanczos_3.png</url><title>T. Aslesh</title><link>https://Athos213.github.io/MoultonResearchGroup/author/t.-aslesh/</link></image><item><title>Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy</title><link>https://Athos213.github.io/MoultonResearchGroup/publication/pmid-35193974/</link><pubDate>Tue, 01 Mar 2022 00:00:00 +0000</pubDate><guid>https://Athos213.github.io/MoultonResearchGroup/publication/pmid-35193974/</guid><description/></item></channel></rss>